Form 4 for ONC BeOne Medicines Ltd.
Accepted 2024-10-01 00:00:00 ET · period of report 2024-09-27 · accession 0001651308-24-000126 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-10-01 | 2024-09-27 | ONC | Wang Lai | Gbl Head of R, D | S - Sale | $220.35 | -5,000 | 0 | -100% | -$1.10M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | American Depositary Shares | 2024-09-27 | S | D | 5,000 | $220.35 | 0 | I See Footnote | — | — | (F1) These securities are held by Wang Holdings LLC, the limited liability company interests of which are owned by the Reporting Person, his spouse and a trust created by the Reporting Person for the benefit of his spouse and children, for which the Reporting Person disclaims beneficial ownership. |